The Europe dog dewormers market was anticipated to reach US$ 427.49 million in 2023 and grow at a CAGR of 10.67% between 2023 and 2033. The market is anticipated to be worth US$1,178.20 million by 2033.
Rising dog healthcare expenditures and an increase in the use of e-commerce platforms to buy pet supplies are key reasons driving the Europe dog dewormers market growth. The proliferation of the market is also expected to be fueled by the high number of dogs and their owners. Around 312 million pets, including 92.9 million dogs, were owned in the Europe region as of 2021, according to FEDIAF's 2022 research.
| Attributes | Details |
|---|---|
| Europe Dog Dewormers Market CAGR (From 2023 to 2033) | 10.67% |
| Europe Dog Dewormers Market Size (2023) | US$ 427.49 million |
| Europe Dog Dewormers Market Size (2033) | US$ 1,178.20 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Research and development, medical supplies, and veterinary services were all affected by the pandemic's paralyzing spread, which affected nearly every region of Europe. After the WHO classified the illness as a pandemic due to its widespread nature, several European countries, including Germany, the United Kingdom, and Russia, issued a complete lockdown to halt the spread. As a result, many other industries have suffered, including the animal healthcare sector.
A few of the Europe dog dewormers market repercussions of the outbreak include decreased veterinary clinic admission rates and disruptions in the dewormer drug supply chain. Thanks to e-commerce channels, the pandemic constraints' simplicity, and the return of veterinary services, the market's growth resumed in the latter half of 2020.
The increasing population of dogs is predicted to increase, which might increase the demand for veterinary services and total costs. Dog insurance costs between US$ 16 and US$ 53 (or EUR 15-50) a month, depending on the breed of the dog, according to N26 GmbH, a German insurance-providing firm, in October 2020. The cost of routine veterinarian care for each visit ranges from US$ 52.8 to US$ 63.36, according to the same source.
Similar figures show that dog owners in the United Kingdom spend between US$ 6,122 and US$ 14,937 on their pets over their lifetimes, according to the People's Dispensary for Sick Animals PDSA 2022.
The Europe dog dewormers market growth is being fueled by consumers' desire to pay more for their dog's healthcare.
Principal Consultant
The Europe dog dewormers market participants are spending more time and money on research and development efforts, creating new products, and improving existing ones to achieve better animal health outcomes.
In the past 12 months, Norbrook has launched five research and development initiatives, and in the following two years, it aims to create ten additional goods. Elanco indicated in its investor presentations that veterinarians, farmers, and pet owners were shifting their purchase habits to online platforms. The corporation has so recognized the ongoing improvement of the digital ecosphere as a key growth driver.
The adverse effects of dog dewormers and the stringent regulatory criteria for the approval procedure of dog dewormers are the primary factors that can restrain the Europe dog dewormers market growth.
In addition, it is anticipated that unclear legislation governing the labeling and promotion of pet care goods is anticipated to reduce sales for the companies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Previous years have witnessed rapid expansion in the European dog deworming market. The market's estimated value in 2018 was US$ 562 million, and it is anticipated that by 2022, it will have grown to US$ 712 million, with a CAGR of 5.2% from 2018 to 2022.
There are a variety of elements that contribute to the market's expansion. For starters, there is now more of a demand for pet healthcare products, such as deworming solutions, thanks to the rising pet ownership rates, notably in Europe. The demand for these products has also surged as pet owners become more aware of the health advantages of deworming.
The development of the market is also being fueled by the release of cutting-edge deworming treatments and the increase in zoonotic illnesses like roundworm and hookworm. Additionally, the market is growing as a result of the rising adoption rate for dogs, particularly in metropolitan areas.
| Attributes | Details |
|---|---|
| Veterinary Clinic Segment - Market Share | 39% |
| E-Commerce Segment - CAGR | 11.08% |
Due to the expanding adoption of companion animals, particularly dogs, which has raised the count of veterinary clinic services in Europe, the veterinary clinic segment is predicted to have a considerable revenue share of about 39% during the projection period of 2023 to 2033. The region's rising dog population rate is contributing to the Europe dog dewormers market expansion.
The retail/pet stores market is anticipated to expand significantly as well. The desire for fast access to a wide range of pet items is rising in Europe as more people keep pets.
During the forecast period of 2023 to 2033, the e-commerce segment is predicted to experience a robust growth rate of 11.08%. During the epidemic, online sales of dog dewormer products in Europe have significantly increased. E-commerce has developed into a practical and straightforward distribution channel for pet care products.
These online stores offer a large selection of dewormers at reasonable costs in a variety of flavors, sizes, and volumes. These platforms make it possible for customers to buy more quickly and effectively. Additionally, well-known e-commerce sites like My Lovely Dog (Poland) have permitted subscription programs, creating larger chances for category growth.
| Attributes | Details |
|---|---|
| Market Share | 14% |
With a share of almost 14% in the forecast period, the United Kingdom is predicted to dominate the European market. The main element boosting the dog dewormers market expansion in Europe is the United Kingdom government's introduction of different regulations and guidelines to avoid parasite diseases in dogs.
For particular parasite infection risk categorized animals, the ESCCAP United Kingdom advises deworming more frequently (up to monthly). More than 12 million dogs are owned in households nationwide, according to FEDIAF 2022.
Norway's dog dewormers market is expected to develop at a swift rate throughout the forecast period. In Norway, the fox dwarf tapeworm known as echinococcus must be treated on all imported dogs. Dogs may not be in grave danger from this infection, but humans may be at greater risk.
According to the local headlines in Norway, a mystery intestinal sickness that produced diarrhea and vomiting had struck the nation's canine population.
For many years, the nation has also recorded a moderate prevalence rate of intestinal parasite diseases in dogs. There are anticipated to be 490 thousand dogs in the country in 2021 compared to 452,000 in 2010. These elements contribute fairly to the market's projected growth rate.
The Europe dog dewormers market is highly competitive. Many market players concentrate their attention on organic growth methods including product approvals, product launches, and other things like patents and events. Acquisitions and partnerships along with collaborations were examples of inorganic growth tactics that were observed in the market.
Companies now concentrate on creating high-quality, nutrient-rich animal food products to diversify their product offerings. To boost their product revenues, they are also increasing their production capacity across all leading Europe dog dewormers markets.
The market participants’ ability to grow their customers and businesses is due to these actions. With the increasing demand for table stands in the worldwide industry, it is projected that market participants in the Europe dog dewormers market are anticipated to have attractive growth prospects in the future.
| Date | January 2021 |
|---|---|
| Company | Boehringer Ingelheim International GmbH |
| Details | NexGard medicines, which are used as antiparasitics in dogs and cats, were given marketing authorization approval in Europe by Boehringer Ingelheim International GmbH in January 2021. The European Commission and European Medicines Agency (EMA) approved the request. |
| Date | April 2019 |
|---|---|
| Company | Norbrook Laboratories ltd |
| Details | Taurador, a topical dewormer for the treatment of lungworms, gastrointestinal roundworms, warbles, and other worms in cattle, was introduced in April 2019 by Norbrook Laboratories Ltd. |
| Date | April 2019 |
|---|---|
| Company | Bimeda |
| Details | Bimectin Plus, an injectable dewormer for cattle, was introduced by Bimeda in April 2019. |
| Date | January 11, 2023 |
|---|---|
| Company | Merck |
| Details | With Imago remaining the surviving corporation, Merck intends to complete the acquisition of Imago by merging its wholly-owned subsidiary with and into the latter. All shares not tendered into the offer are anticipated to be canceled and converted into the right to receive cash equal to the US$ 36.00 offer price per share, without interest, and subject to deduction for any necessary tax withholding. After the transaction is complete, Imago is anticipated to become a fully owned subsidiary of Merck, and its common stock won't be listed or traded on the Nasdaq Global Market any longer. |
| Date | April 2022 |
|---|---|
| Company | SAVAVET |
| Details | The debut of ORAPET, a novel new treatment method to support healthy gums, teeth, mouths, and breath in cats and dogs, was announced by SAVAVET, a business division of SAVA Healthcare Limited. Three clinically proven probiotic bacterial strains are found in ORAPET, which provides veterinarians and pet owners with a remarkably simple way to treat dental disorders at all stages of periodontitis. |
| Date | September 2022 |
|---|---|
| Company | Zoetis Inc. |
| Details | Jurox, a privately held animal health firm that creates, produces, and sells a variety of veterinary medications for treating livestock and companion animals, has been acquired by Zoetis Inc. Jurox's headquarters are in Australia, and it also has regional offices in New Zealand, the United States, Canada, and the United Kingdom. |
The market will register a 10.67% CAGR through 2033.
Pet health awareness and increasing adoption fuel market.
From 2018 to 2022, the market expanded at a 5.2% CAGR.
The United Kingdom will expand at a 14% CAGR until 2033.
By 2033, the market will reach US$ 1,178.20 million.
1. Executive Summary | Europe Dog Dewormers Marke 1.1. Europe Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Target Worms 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Target Worms, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Target Worms, 2023 to 2033 5.3.1. Roundworms 5.3.2. Hookworms 5.3.3. Tapeworms 5.3.4. Heartworms 5.3.5. Whipworms 5.4. Y-o-Y Growth Trend Analysis By Target Worms, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Target Worms, 2023 to 2033 6. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 6.3.1. Veterinary Clinics 6.3.2. Pet Stores 6.3.3. Online Retailing 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 7. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. Europe 7.4. Market Attractiveness Analysis By Region 8. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. Germany 8.2.1.2. United Kingdom. 8.2.1.3. France 8.2.1.4. Spain 8.2.1.5. Italy 8.2.1.6. Rest of Europe 8.2.2. By Target Worms 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Target Worms 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Key Countries Dog Dewormers Market Analysis 9.1. Germany 9.1.1. Pricing Analysis 9.1.2. Market Share Analysis, 2022 9.1.2.1. By Target Worms 9.1.2.2. By Distribution Channel 9.2. United Kingdom. 9.2.1. Pricing Analysis 9.2.2. Market Share Analysis, 2022 9.2.2.1. By Target Worms 9.2.2.2. By Distribution Channel 9.3. France 9.3.1. Pricing Analysis 9.3.2. Market Share Analysis, 2022 9.3.2.1. By Target Worms 9.3.2.2. By Distribution Channel 9.4. Spain 9.4.1. Pricing Analysis 9.4.2. Market Share Analysis, 2022 9.4.2.1. By Target Worms 9.4.2.2. By Distribution Channel 9.5. Italy 9.5.1. Pricing Analysis 9.5.2. Market Share Analysis, 2022 9.5.2.1. By Target Worms 9.5.2.2. By Distribution Channel 9.6. Rest of Europe 9.6.1. Pricing Analysis 9.6.2. Market Share Analysis, 2022 9.6.2.1. By Target Worms 9.6.2.2. By Distribution Channel 10. Market Structure Analysis 10.1. Competition Dashboard 10.2. Competition Benchmarking 10.3. Market Share Analysis of Top Players 10.3.1. By Regional 10.3.2. By Target Worms 10.3.3. By Distribution Channel 11. Competition Analysis 11.1. Competition Deep Dive 11.1.1. Merck & Co., Inc. 11.1.1.1. Overview 11.1.1.2. Product Portfolio 11.1.1.3. Profitability by Market Segments 11.1.1.4. Sales Footprint 11.1.1.5. Strategy Overview 11.1.1.5.1. Marketing Strategy 11.1.2. Boehringer Ingelheim International GmbH 11.1.2.1. Overview 11.1.2.2. Product Portfolio 11.1.2.3. Profitability by Market Segments 11.1.2.4. Sales Footprint 11.1.2.5. Strategy Overview 11.1.2.5.1. Marketing Strategy 11.1.3. Virbac 11.1.3.1. Overview 11.1.3.2. Product Portfolio 11.1.3.3. Profitability by Market Segments 11.1.3.4. Sales Footprint 11.1.3.5. Strategy Overview 11.1.3.5.1. Marketing Strategy 11.1.4. Elanco 11.1.4.1. Overview 11.1.4.2. Product Portfolio 11.1.4.3. Profitability by Market Segments 11.1.4.4. Sales Footprint 11.1.4.5. Strategy Overview 11.1.4.5.1. Marketing Strategy 11.1.5. Ceva 11.1.5.1. Overview 11.1.5.2. Product Portfolio 11.1.5.3. Profitability by Market Segments 11.1.5.4. Sales Footprint 11.1.5.5. Strategy Overview 11.1.5.5.1. Marketing Strategy 11.1.6. Zoetis 11.1.6.1. Overview 11.1.6.2. Product Portfolio 11.1.6.3. Profitability by Market Segments 11.1.6.4. Sales Footprint 11.1.6.5. Strategy Overview 11.1.6.5.1. Marketing Strategy 11.1.7. PetIQ, LLC 11.1.7.1. Overview 11.1.7.2. Product Portfolio 11.1.7.3. Profitability by Market Segments 11.1.7.4. Sales Footprint 11.1.7.5. Strategy Overview 11.1.7.5.1. Marketing Strategy 11.1.8. Sava Healthcare Limited 11.1.8.1. Overview 11.1.8.2. Product Portfolio 11.1.8.3. Profitability by Market Segments 11.1.8.4. Sales Footprint 11.1.8.5. Strategy Overview 11.1.8.5.1. Marketing Strategy 11.1.9. Beaphar 11.1.9.1. Overview 11.1.9.2. Product Portfolio 11.1.9.3. Profitability by Market Segments 11.1.9.4. Sales Footprint 11.1.9.5. Strategy Overview 11.1.9.5.1. Marketing Strategy 11.1.10. Drontal Plus 11.1.10.1. Overview 11.1.10.2. Product Portfolio 11.1.10.3. Profitability by Market Segments 11.1.10.4. Sales Footprint 11.1.10.5. Strategy Overview 11.1.10.5.1. Marketing Strategy 12. Assumptions & Acronyms Used 13. Research Methodology
Explore Consumer Product Insights
View Reports
Europe Dog Dewormers Market
